Washington University School of MedicineAdvanced Technology Consortium

Members Credentialing Protocols Publications Resources Home

RADIATION THERAPY ONCOLOGY GROUP

Protocols Closed to Accrual

RTOG 9406

A PHASE I/II DOSE ESCALATION STUDY USING THREE DIMENSIONAL CONFORMAL RADIATION THERAPY FOR ADENOCARCINOMA OF THE PROSTATE

RTOG 9311

A PHASE I/II DOSE ESCALATION STUDY USING THREE DIMENSIONAL CONFORMAL RADIATION THERAPY IN PATIENTS WITH INOPERABLE, NON-SMALL CELL LUNG CANCER

RTOG 9803

PHASE I/II RADIATION DOSE ESCALATION STUDY APPLYING CONFORMAL RADIATION THERAPY IN SUPRATENTORIAL GLIOBLASTOMA MULTIFORME

RTOG 0022

PHASE I/II STUDY OF CONFORMAL AND INTENSITY MODULATED IRRADIATION FOR OROPHARYNGEAL CANCER

RTOG 0117

PHASE I/II DOSE INTENSIFICATION STUDY USING THREE DIMENSIONAL CONFORMAL RADIATION THERAPY AND CONCURRENT CHEMOTHERAPY FOR PATIENTS WITH INOPERABLE, NON-SMALL CELL LUNG CANCER

RTOG 0225

A PHASE II STUDY OF INTENSITY MODULATED RADIATION THERAPY (IMRT) +/- CHEMOTHERAPY FOR NASOPHARYNGEAL CANCER

RTOG 0234

A PHASE II RANDOMIZED TRIAL OF SURGERY FOLLOWED BY CHEMORADIOTHERAPY PLUS C225 (CETUXIMAB) FOR ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK  

RTOG 0236

A PHASE II TRIAL OF STEREOTACTIC BODY RADIATION THERAPY (SBRT) IN THE TREATMENT OF PATIENTS WITH MEDICALLY INOPERABLE STAGE I/II NON-SMALL CELL LUNG CANCER  

RTOG 0319

A PHASE I/II TRIAL TO EVALUATE THREE DIMENSIONAL CONFORMAL RADIATION THERAPY (3D-CRT) CONFINED TO THE REGION OF THE LUMPECTOMY CAVITY FOR STAGE I AND IIA BREAST CARCINOMA

RTOG 0321

A PHASE I/II TRIAL OF COMBINED HIGH DOSE RATE BRACHYTHERAPY AND EXTERNAL BEAM RADIOTHERAPY FOR ADENOCARCINOMA OF THE PROSTATE

RTOG 0421

A PHASE III TRIAL FOR LOCALLY RECURRENT, PREVIOUSLY IRRADIATED HEAD AND NECK CANCER: CONCURRENT RE-IRRADIATION AND CHEMOTHERAPY VERSUS CHEMOTHERAPY ALONE  

RTOG 0417

A PHASE II STUDY OF AN ORAL EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR (EGFR TKI) ZD 1839 (IRESSA(r)) IN COMBINATION WITH DEFINITIVE RADIOTHERAPY AND CISPLATIN CHEMOTHERAPY IN UNTREATED PATIENTS WITH LOCALLY ADVANCED CERVICAL CARCINOMA

RTOG 0435

A RANDOMIZED, PHASE III, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PALIFERMIN (NSC# 740548; IND #6370) FOR THE REDUCTION OF ORAL MUCOSITIS IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK CANCER RECEIVING RADIATION THERAPY WITH CONCURRENT CHEMOTHERAPY (FOLLOWED BY SURGERY FOR SELECTED PATIENTS)

RTOG 0515

A COMPARATIVE STUDY OF GROSS TUMOR VOLUME DEFINITION WITH OR WITHOUT PET FUSION FOR PATIENTS WITH NON-SMALL CELL LUNG CARCINOMA

RTOG 0529

A PHASE II EVALUATION OF DOSE-PAINTED IMRT IN COMBINATION WITH 5-FLUOROURACIL AND MITOMYCIN-C FOR REDUCTION OF ACUTE MORBIDITY IN CARCINOMA OF THE ANAL CANAL